Uncontrolled hypertension defined as sustained systolic blood pressure (BP) >  mmHg or diastolic BP >  mmHg; (patients with initial BP elevations are eligible if initiation or adjustment of BP medication lowers pressure to meet entry criteria)
Uncontrolled high blood pressure defined as systolic blood pressure (BP) >  mmHg or diastolic BP  mmHg with or without anti-hypertensive medication; patients with initial BP elevations are eligible if initiation or adjustment of BP medication lowers pressure to meet entry criteria
Uncontrolled high blood pressure defined as systolic blood pressure (BP) greater than or equal to  mmHg or diastolic BP greater than or equal to  mmHg with or without anti-hypertensive medication. Patients with initial BP elevations are eligible if initiation or adjustment of BP medication lowers pressure to meet entry criteria.
Uncontrolled hypertension, defined as systolic blood pressure (BP) >  mmHg or diastolic BP >  mmHg.
Uncontrolled or poorly controlled hypertension (systolic blood pressure [BP] >=  mmHg or diastolic BP >=  mmHg); Note: an isolated reading that is not sustained will be permitted
Uncontrolled hypertension defined as sustained systolic BP >  mmHg or diastolic BP >  mmHg. (Patients with initial BP elevations are eligible if initiation or adjustment of BP medication lowers pressure to meet entry criteria.) Patients requiring greater than or equal to  BP medications are not eligible.
Systolic blood pressure (BP) not deemed clinically controlled by the investigator.
No grade  or  hypertension (systolic blood pressure [BP] >  and or diastolic BP > ) that cannot be controlled with medication prior to registration
Uncontrolled hypertension, i.e., blood pressure (BP) of >= /; patients who have a history of hypertension controlled by medication must be on a stable dose (for at least one month) and meet all other inclusion criteria; or
Uncontrolled hypertension (blood pressure [BP] > / mmHg)
Uncontrolled hypertension (systolic blood pressure [BP] >  mmHg or diastolic BP >  mmHg)
Uncontrolled hypertension. Patients with a history of hypertension are allowed provided blood pressure is controlled by anti-hypertensive therapy. Note that this is NOT a criterion related to particular blood pressure (BP) results at the time of assessment for eligibility, nor does it apply to acute BP excursions that are related to iatrogenic causes, acute pain or other transient, reversible causes
Chronically uncontrolled hypertension, defined conventionally as consistent systolic pressures above  or diastolic pressures above  despite anti-hypertensive therapy. Note that this is NOT a criterion related to particular blood pressure (BP) results at the time of assessment for eligibility, nor does it apply to acute BP excursions that are related to iatrogenic causes, acute pain or other transient, reversible causes. (for example doctors visit related stress i.e. \white coat syndrome\.
Uncontrolled cardiac disease, including unstable angina, uncontrolled hypertension (i.e. sustained systolic BP > mmHg or diastolic BP > mmHg), or need to change medication due to lack of disease control within  weeks prior to the provision of consent;
Uncontrolled hypertension defined as a systolic blood pressure (BP) >  mmHg or diastolic BP >  mmHg, with or without anti-hypertensive medications
Uncontrolled hypertension (HTN); sustained blood pressure (BP) greater than / mmHg
Blood pressure (BP) <  mmHg (systolic) and <  mmHg (diastolic); initiation or adjustment of BP medication is permitted prior to registration provided that the average of three BP readings at a visit prior to registration is < / mmHg; NOTE: all patients with secretory pheochromocytoma or paraganglioma are REQUIRED to: ) be evaluated in consultation by a hypertension specialist with specific experience in the management of hypertension in the setting of catecholamine-secreting tumors (usually an endocrinologist, nephrologist, or a cardiologist), and in the setting of hormone-associated hypertension) receive alpha- and beta-adrenergic blockade for at least - days prior to initiation of lenvatinib; the hypertension specialist of record for each patient should be committed to closely following the patient during the clinical study with evaluation by said specialist required at cycle  and  and thereafter on an as needed basis
Uncontrolled hypertension (systolic blood pressure [BP] >=  mmHg or diastolic BP >=  mmHg) or other medical condition that could jeopardize the assessment of toxicity on study
Uncontrolled hypertension (systolic blood pressure [BP] >=  mmHg or diastolic BP >=  mmHg); patients with a history of hypertension are allowed provided blood pressure is controlled by anti-hypertensive treatment
Systolic blood pressure (BP) >  mmHg or diastolic BP >  mmHg despite optimal medical management
Uncontrolled hypertension, i.e., blood pressure (BP) of >= /; patients who have a history of hypertension controlled by medication must be on a stable dose and meet all other inclusion criteria; or
Resting systolic blood pressure (BP) <  mmHg
Hypertension defined as systolic BP >=  mmHg or diastolic BP >=  mmHg despite optimal medical management
Uncontrolled hypertension defined as a systolic BP greater than  mmHg or diastolic BP greater than  mmHg, with or without anti-hypertensive medications. (Patients with hypertension that is well controlled on medication are eligible.)
Severe hypertension (diastolic BP >  on medication).
Uncontrolled hypertension (systolic blood pressure [BP] >=  mmHg or diastolic BP >=  mmHg); patients with a history of hypertension are allowed provided blood pressure is controlled by anti-hypertensive treatment
Uncontrolled high blood pressure defined as systolic BP greater than or equal to  mmHg or diastolic BP greater than or equal to  mmHg with or without anti-hypertensive medication. Patients with initial BP elevations are eligible if initiation or adjustment of BP medication lowers pressure to meet entry criteria.
uncontrolled hypertension (systolic BP>  mmHg or diastolic BP >  mmHg despite antihypertensive treatment);
Severe hypertension (diastolic BP >  on medication)
Uncontrolled hypertension defined as sustained systolic blood pressure (BP) >  mmHg or diastolic BP >  mmHg; (patients with initial BP elevations are eligible if initiation or adjustment of BP medication lowers pressure to meet entry criteria)
Patients with uncontrolled hypertension (requirement for more than  blood pressure [BP] medications or grade  or higher BP elevation while on adequate doses of not more than  antihypertensive agents) are excluded from the study
Mean arterial blood pressure (BP) of less than  mmHg
No history of the following\r\n* Prior brain metastases\r\n* Leptomeningeal disease\r\n* Seizures\r\n* Class  or  congestive heart failure\r\n* Uncontrolled hypertension (systolic blood pressure [BP] >  mmHg or diastolic BP >  mmHg) despite optimal medical management\r\n* Major surgery =<  weeks of registration
Have uncontrolled hypertension (systolic blood pressure [BP] >  mmHg or diastolic BP >  mmHg).
Resting systolic blood pressure (BP) <  mmHg
Hypertension defined as systolic BP >=  mmHg or diastolic BP >=  mmHg despite optimal medical management
Poorly-controlled hypertension as defined blood pressure (BP) > / mmHg, or systolic (S) BP >  mmHg when diastolic (D) BP <  mmHg, on at least  repeated determinations on separate days within  months prior to study enrollment
Uncontrolled hypertension defined as sustained systolic blood pressure (BP) >  mmHg or diastolic BP >  mmHg; (patients with initial BP elevations are eligible if initiation or adjustment of BP medication lowers pressure to meet entry criteria)
Blood pressure (BP) >  mmHg (systolic) and >  mmHg (diastolic); initiation or adjustment of BP medication is permitted prior to registration provided that the average of three BP readings at a visit prior to registration is < / mmHg
Uncontrolled hypertension (systolic blood pressure [BP] >=  mmHg or diastolic BP >=  mmHg); patients with a history of hypertension are allowed provided blood pressure is controlled by anti-hypertensive therapy
Systolic blood pressure (BP) >  mmHg or diastolic BP >  mmHg.
uncontrolled hypertension (systolic BP ?  mmHg or diastolic BP ?  mmHg) at screening, despite optimal antihypertensive therapy,
Severe hypertension (diastolic BP >  on medication)
Uncontrolled hypertension, i.e., blood pressure (BP) of >= /; patients who have a history of hypertension controlled by medication must be on a stable dose (for at least one month) and meet all other inclusion criteria
Uncontrolled hypertension (systolic blood pressure [BP] >=  mmHg or diastolic BP >=  mmHg); patients with a history of hypertension are allowed provided blood pressure is controlled by anti-hypertensive treatment
Uncontrolled hypertension (systolic blood pressure [BP] >=  mmHg or diastolic BP >=  mmHg); patients with a history of hypertension are allowed provided blood pressure is controlled by anti-hypertensive treatment
Subjects with uncontrolled hypertension (systolic blood pressure [BP] > mmHg or diastolic BP > mmHg) at screening are excluded. Subjects requiring  or more medications to control hypertension are eligible with Medical Monitor approval.
Patients with a history of hypertension MUST have hypertension adequately controlled (blood pressure [BP] < /) with appropriate anti-hypertensive therapy or diet prior to study entry; Note: To be eligible a subject must have an average of BP below / based on  separate measures; if the subject has a record of BP recordings taken at home, =< % of BPs taken should have numbers > /
Patients must have blood pressure (BP) no greater than  mmHg (systolic) and  mmHg (diastolic) for eligibility; initiation or adjustment of BP medication is permitted prior to study entry provided that the average of three BP readings at a visit prior to enrollment is less than / mmHg
Blood pressure (BP) no greater than  mmHg (systolic) and  mmHg (diastolic) for eligibility; initiation or adjustment of BP medication is permitted prior to study entry provided that the average of three BP readings on baseline assessment prior to enrollment is less than / mmHg
Uncontrolled hypertension defined as systolic blood pressure (BP) >=  mmHg or diastolic BP >=  mmHg with or without antihypertensive medication, based on a mean of  measurements at approximately -minute intervals
Significant co-morbidity that could affect the safety or evaluability of participants, specifically including: \r\n* Chronically uncontrolled hypertension, defined conventionally as consistent systolic pressures above  or diastolic pressures above  despite therapy; note that this may be better established with home blood pressure (BP) readings than with clinic visit results; note further that this is NOT a criterion related to particular BP results at the time of assessment for eligibility, nor does it apply to acute BP excursions that are related to iatrogenic causes, acute pain or other transient, reversible causes; the intent is to exclude patients that may have unrecognized renal damage from chronic, uncontrolled hypertension, NOT to exclude patients who may be hypertensive acutely; there are no absolute criteria for BP readings with respect to eligibility (as determined by treating physician)\r\n* Uncontrolled diabetes mellitus, defined as: hemoglobin (Hgb) Ac > .%; or symptomatic hypoglycemic episodes >  per week during the two months prior to eligibility evaluation; or more than  glucose excursion to >  mg/dL in prior two months--unless clearly iatrogenic and the cause has been eliminated \r\n* Lung disease requiring supplemental oxygen \r\n* Known chronic liver disease causing either fibrosis or synthetic dysfunction \r\n* Known human immunodeficiency virus (HIV) infection \r\n* Overt psychosis, mental disability or being otherwise incompetent to grant informed consent or a history of non-compliance with medical care
Uncontrolled hypertension (BP ?/ mmHg despite medical therapy)
Uncontrolled hypertension (blood pressure [BP] >  diastolic despite treatment with maximum doses of at least  simultaneous or concurrent antihypertensives over a -month period)
Severe hypertension (diastolic blood pressure [BP] >  on medication)
Uncontrolled hypertension (systolic blood pressure [BP] ?  millimeters of mercury [mmHg] or diastolic BP ?  mmHg).
Uncontrolled hypertension (systolic blood pressure [BP] >=  mmHg or diastolic BP >=  mmHg); patients with a history of hypertension are allowed provided blood pressure is controlled by anti-hypertensive treatment
Mean arterial blood pressure (BP) of less than  mmHg.
Patients must have resting blood pressure (BP) no greater than  mmHg (systolic) or  mmHg (diastolic) for eligibility; initiation or adjustment of BP medication is permitted prior to study entry
Uncontrolled hypertension, i.e., blood pressure (BP) of >= /; patients who have a history of hypertension controlled by medication must be on a stable dose (for at least one month) and meet all other inclusion criteria
Uncontrolled hypertension (systolic blood pressure [BP] >=  mmHg or diastolic BP >=  mmHg) despite medical treatment; patients with a history of hypertension are allowed provided blood pressure is controlled by anti-hypertension treatment
Subjects must have blood pressure (BP) no greater than  mmHg (systolic) and  mmHg (diastolic) for eligibility; initiation or adjustment of BP medication is permitted prior to study entry provided that the average of three BP readings at the time of enrollment is =< / mmHg
Patients must have blood pressure (BP) no greater than  mmHg (systolic) and  mmHg (diastolic) for eligibility; initiation or adjustment of BP medication is permitted prior to study entry provided that the BP reading prior to enrollment is no greater than / mmHg
Uncontrolled hypertension, defined as systolic BP > or diastolic > despite therapy.
Uncontrolled hypertension (systolic blood pressure [BP] >=  mmHg or diastolic BP >=  mmHg); patients with a history of hypertension are allowed provided blood pressure is controlled by anti-hypertensive treatment
No uncontrolled hypertension (BP >/mmHg despite full doses of  anti-hypertensive medication).
Baseline arterial blood pressure (BP) >= / mmHg, despite pharmacologic treatment with antihypertensive agents; if the arterial BP measurements at screening are >= / mmHg in a patient not on pharmacologic treatment for hypertension (HTN), we will initiate pharmacologic therapy and reassess the parameters after  week; at that time, patient will be eligible for enrollment on the study if arterial BP is found < / mmHg on antihypertensive therapy
Patients with uncontrolled hypertension (defined as sustained stage  hypertension, i.e., systolic blood pressure [BP] >=  mmHg or diastolic BP >=  mmHg) with or without medical therapy
Poorly controlled hypertension (systolic blood pressure [BP] >=  mmHg or diastolic BP >=  mmHg) on three or more readings in the past  months
Severe hypertension (diastolic BP >  on medication)
All patients must also have  pre-op blood pressures (BP) to average for determining individual perioperative BP goal; it is preferred to utilize office visit BP's to reduce \whitecoat\ effect seen the morning of surgery
Uncontrolled hypertension, i.e., blood pressure (BP) of >= /; patients who have a history of hypertension controlled by medication must be on a stable dose (for at least one month) and meet all other inclusion criteria; or
Uncontrolled hypertension (systolic blood pressure [BP] >  mmHg or diastolic BP >  mmHg), or as determined by the investigator during screening.
Systolic/diastolic blood pressure (BP) greater than or equal to /, or below / (one re-screen allowed)
Uncontrolled high blood pressure (BP) >= /; persons can be re-screened after controlled
Severe hypertension (diastolic BP >  on medication)
Uncontrolled hypertension (systolic blood pressure [BP] >=  mmHg or diastolic BP >=  mmHg)
Uncontrolled hypertension, blood pressure (BP) > / mmHg; patients with elevated BP may enroll once BP is corrected